Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Poor Drug Response”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Not applicableLooking for participantsNCT06645379
What this trial is testing

Application of Platelet-rich Plasma (PRP) in Reproductive Medicine

Who this might be right for
Premature Ovarian InsufficiencyIntrauterine AdhesionPoor Ovarian Response+2 more
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 300
Not applicableUnknownNCT03485300
What this trial is testing

The Prevalence of Sub Optimal Anti Coagulation

Who this might be right for
Poor Drug Response
Assiut University 50
Large-scale testing (Phase 3)Ended earlyNCT01230827
What this trial is testing

The Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS)

Who this might be right for
Juvenile Idiopathic Arthritis
Janssen Research & Development, LLC 173
Not applicableUnknownNCT03830697
What this trial is testing

A Trial Study on Acupuncture Treatment of Poor Ovarian Response

Who this might be right for
Poor Ovarian Response
Shaanxi Hospital of Traditional Chinese Medicine 140
Not applicableStudy completedNCT03800407
What this trial is testing

Contributing Factors for Poor HIV Treatment Response in Children With TB/HIV Coinfection

Who this might be right for
TuberculosisHuman Immunodeficiency VirusCoinfection
University of Florida 213
Large-scale testing (Phase 3)Study completedNCT00383162
What this trial is testing

Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2)

Who this might be right for
Migraine Disorders
GlaxoSmithKline 173
Not applicableStudy completedNCT01857245
What this trial is testing

Intensive Models of HCV Care for Injection Drug Users

Who this might be right for
Hepatitis CMedication Adherence
Prisma Health-Upstate 150
Testing effectiveness (Phase 2)UnknownNCT04351308
What this trial is testing

Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma

Who this might be right for
OsteosarcomaSurvivalChemotherapy Effect+1 more
Peking University People's Hospital 60
Large-scale testing (Phase 3)Study completedNCT01475851
What this trial is testing

Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs

Who this might be right for
Hepatitis B, Chronic
GlaxoSmithKline 34
Large-scale testing (Phase 3)Study completedNCT00382993
What this trial is testing

Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)

Who this might be right for
Migraine Disorders
GlaxoSmithKline 169